[go: up one dir, main page]

IN2014DN09993A - - Google Patents

Info

Publication number
IN2014DN09993A
IN2014DN09993A IN9993DEN2014A IN2014DN09993A IN 2014DN09993 A IN2014DN09993 A IN 2014DN09993A IN 9993DEN2014 A IN9993DEN2014 A IN 9993DEN2014A IN 2014DN09993 A IN2014DN09993 A IN 2014DN09993A
Authority
IN
India
Prior art keywords
apis
gamma
useful
preparation
sterile
Prior art date
Application number
Inventor
Mario Leone
Pierfrancesco Morosini
Original Assignee
Icrom Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icrom Spa filed Critical Icrom Spa
Publication of IN2014DN09993A publication Critical patent/IN2014DN09993A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0029Radiation
    • A61L2/0035Gamma radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08Radiation
    • A61L2/081Gamma radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/20Targets to be treated
    • A61L2202/21Pharmaceuticals, e.g. medicaments, artificial body parts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention refers to a process for preparing sterile active pharmaceutical ingredients (APIs) useful in the preparation of sterile product for ophthalmic use. The process comprises the gamma- ray sterilization treatment of the APIs powder in a protective atmosphere.
IN9993DEN2014 2012-05-09 2012-05-09 IN2014DN09993A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2012/000136 WO2013168186A1 (en) 2012-05-09 2012-05-09 Production of sterile active pharmaceutical ingredients

Publications (1)

Publication Number Publication Date
IN2014DN09993A true IN2014DN09993A (en) 2015-08-14

Family

ID=46321406

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9993DEN2014 IN2014DN09993A (en) 2012-05-09 2012-05-09

Country Status (16)

Country Link
US (1) US10953115B2 (en)
EP (1) EP2846845B1 (en)
JP (1) JP6122485B2 (en)
KR (1) KR101966830B1 (en)
CN (1) CN104487099B (en)
BR (1) BR112014027885B1 (en)
CA (1) CA2872336C (en)
EA (1) EA028596B1 (en)
ES (1) ES2624250T3 (en)
HR (1) HRP20170529T1 (en)
HU (1) HUE034356T2 (en)
IN (1) IN2014DN09993A (en)
MX (1) MX349920B (en)
PL (1) PL2846845T3 (en)
PT (1) PT2846845T (en)
WO (1) WO2013168186A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210145836A1 (en) * 2012-05-09 2021-05-20 Icrom Spa Production of sterile active pharmaceutical ingredients
WO2017134540A1 (en) * 2016-02-05 2017-08-10 Innopharma, Inc. Process of manufacturing a stable, ready to use infusion bag for an oxidation sensitive formulation
EP3429555B1 (en) * 2016-03-14 2020-04-29 AuXin Surgery SA Mesna formulation and its use
BE1024110B1 (en) * 2016-10-18 2017-11-16 Auxin Surgery Sa Chemical assisted dissection device, method and formulation
DE102017107124A1 (en) * 2017-04-03 2018-10-04 Ferton Holding S.A. Powder for cleaning an internal body part and / or an implant, process for producing such a powder and suitable uses
WO2021237091A1 (en) * 2020-05-21 2021-11-25 Coherus Biosciences, Inc. Systems and methods for producing sterile injection devices
IT202100006794A1 (en) 2021-03-22 2022-09-22 Icrom Srl PROCESS FOR PREPARING INDOCYANINE GREEN

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2004553B1 (en) * 1970-02-02 1971-05-19 Fa B Braun, 3508 Melsungen Process for the production of guide rails from human or animal tissues for the restoration of damaged or destroyed specific tissue parts in the human and animal body
US6071904A (en) 1996-12-11 2000-06-06 Alcon Laboratories, Inc. Process for manufacturing ophthalmic suspensions
US20030095890A1 (en) * 2001-09-24 2003-05-22 Shirley Miekka Methods for sterilizing biological materials containing non-aqueous solvents
AU2006247276A1 (en) * 2005-05-19 2006-11-23 Albiorex, Llc Terminal sterilization of injectable collagen products
AU2007248949B2 (en) * 2006-05-09 2010-04-08 Astrazeneca Ab Parenteral formulation comprising proton pump inhibitor sterilized in its final container by ionizing radiation
CN101528214B (en) * 2006-08-24 2013-06-05 田纳西大学研究基金会 Substituted N-acylanilides and methods of use thereof
GB0626021D0 (en) 2006-12-29 2007-02-07 Insense Ltd The stabilisation of proteins
EP2185112A4 (en) * 2007-08-21 2012-01-18 Harbor Biosciences Inc STABILIZED COMPOSITIONS AND THERAPEUTIC FORMULATIONS
EP2394637A1 (en) 2010-05-21 2011-12-14 Zaklady Farmaceutyczne Polpharma SA Process for obtaining sterile brinzolamide suspensions

Also Published As

Publication number Publication date
ES2624250T3 (en) 2017-07-13
BR112014027885A2 (en) 2017-06-27
US10953115B2 (en) 2021-03-23
US20150141412A1 (en) 2015-05-21
JP2015523327A (en) 2015-08-13
CN104487099A (en) 2015-04-01
EA201491845A1 (en) 2015-02-27
JP6122485B2 (en) 2017-04-26
PL2846845T3 (en) 2017-07-31
EP2846845A1 (en) 2015-03-18
CA2872336C (en) 2019-08-13
MX2014013238A (en) 2015-04-08
KR20150024821A (en) 2015-03-09
MX349920B (en) 2017-08-21
HRP20170529T1 (en) 2017-06-16
CN104487099B (en) 2017-06-20
KR101966830B1 (en) 2019-04-08
EA028596B1 (en) 2017-12-29
WO2013168186A1 (en) 2013-11-14
PT2846845T (en) 2017-06-02
EP2846845B1 (en) 2017-03-01
BR112014027885B1 (en) 2022-07-26
HUE034356T2 (en) 2018-02-28
CA2872336A1 (en) 2013-11-14

Similar Documents

Publication Publication Date Title
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
TN2015000278A1 (en) Autotaxin inhibitors
MY169159A (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
NZ709260A (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
IN2014DN09993A (en)
PH12015502539B1 (en) Cenicriviroc compositions and methods of making and using the same
MX366899B (en) New compounds.
PH12015500713A1 (en) Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
GB201118656D0 (en) New compounds
PH12015500115A1 (en) Glucagon analogues
MX2013001402A (en) Processes for preparing tubulysins.
MX349004B (en) New compounds.
UA116793C2 (en) Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
IN2015DN01164A (en)
IN2015DN01165A (en)
TN2015000007A1 (en) 3-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments
SG11201605868XA (en) Pharmaceutical composition for cancer treatment and pharmaceutical preparation for cancer treatment containing same composition as active ingredient
MX364652B (en) Pharmaceutical formulation comprising ciclesonide.
WO2014027979A3 (en) Tablet formulations comprising tadalafil and dapoxetine
MX2013010415A (en) Treatment of vaginal atrophy as novel indication for myrrh.
EP2863899B8 (en) Formulations for the preparation of immediate-release tablets for oral use containing low-dose mifepristone for the treatment of endometriosis, tablets thus obtained and their preparation process
UA115307C2 (en) APPLICATION OF MEDICINAL PRODUCT CONTAINING RECOMBINANT LECTIN MELINES FOR TREATMENT OF SKIN CANCER
PH12015501179A1 (en) Fixed dose pharmaceutical composition comprising mometasone and azelastine
WO2013109202A3 (en) Pharmaceutical compounds comprising cefetamet
IN2014MU01178A (en)